We find that at every time point assessed in the study (3, 6, 9 and 12 months) following GLP-1 initiation, the GLP-1 treatment cohort achieved a greater magnitude of total weight loss and HbA1C reduction, and a greater proportion of those taking GLP-1s achieved outcomes such as 5%, 10% and 15% weight loss at each follow-up point, as compared to controls
Human clinical trial data for Dihexa remain limited
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
In terms of stress responses, AtGSTL1 is strongly up-regulated in several conditions including biotic interactions, treatment with chemicals, salt and iron-starvation stresses and, to a lesser extent, in response to hypoxia
Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided in the full prescribing information [see Dosage and Administration (2.2), Contraindications (4), Warnings and Precautions (5.1), Drug Interactions (7), and Use in Specific Populations (8.6, 8.7)]